logo
A microwave reflection reality check pushed her to lose 25 kg. Here's how she did it the old-fashioned way

A microwave reflection reality check pushed her to lose 25 kg. Here's how she did it the old-fashioned way

Economic Times9 hours ago
Synopsis
During the Covid lockdown in May 2020, Emma Watson from Aberdeen decided to change her lifestyle. She weighed 78.5 kg and felt uncomfortable. Emma started counting calories and exercising. She used MyFitnessPal and a smartwatch to track her progress. She lost weight and now weighs 53 kg. Emma feels more confident and energetic. She advises others to make sustainable changes.
iStock During the Covid-19 lockdown, Emma Watson from Aberdeen, motivated by her reflection, embarked on a weight loss journey. Eschewing fad diets, she adopted calorie counting, portion control, and increased physical activity, including intermittent fasting. (Image: iStock) When the Covid-19 lockdown brought life to a standstill in May 2020, Emma Watson from Aberdeen found herself facing a moment that would change her life — and it happened in her kitchen. The 34-year-old accountant, who then weighed 78.5 kg, had been aware of slow weight gain over the years. But it wasn't until she caught her own reflection in the dark glass of her microwave door that she realised she had crossed into obesity.
'I just looked at myself and thought, this is the heaviest I've ever been,' Emma told Daily Record . 'Something clicked inside me. I didn't like how I carried my weight, I didn't feel confident. My thighs rubbed, my face was chubby, and I felt uncomfortable in my own skin. Everything in the world felt out of control at that time, but this was something I could control.'
Emma admits she never had a 'bad relationship' with food, but a lifelong sweet tooth meant chocolate and cakes often took priority over healthier meals. As a child, her parents kept her diet balanced, but when she started shopping for herself, the nutritional quality slipped. 'I definitely didn't make the healthiest choices in those first few years,' she said. Instead of opting for extreme diets or quick fixes, Emma decided to take what she calls 'the old-fashioned route' — counting calories, measuring portions, and moving more. Using MyFitnessPal, she tracked everything she ate and calculated her total daily energy expenditure, ensuring she stayed in a calorie deficit. She weighed every meal, bought a smartwatch to monitor her heart rate, sleep, and steps, and started walking regularly. Gradually, she introduced intermittent fasting, limiting her eating window from midday to 8 pm. The result? A drop to 53 kg and a clothing size shift from UK 16 to UK 8.
Emma says the change wasn't just about looks — her energy levels soared, she slept more soundly, and even her walks felt easier. 'I'm much more confident when I look in the mirror now,' she shared. The transformation also inspired friends and family, some of whom are now following her approach. While proud of her achievement, Emma is quick to warn others against quick-result diets. 'It's a marathon, not a sprint. You didn't gain the weight in 30 days, so it's not coming off in 30 days,' she advised in her Daily Record interview. She encourages small, sustainable changes, regular 'maintenance breaks,' and avoiding over-restriction. And as for that microwave moment? Emma says she'll never forget it. 'It was the turning point. Sometimes the smallest reflections can lead to the biggest changes.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GSK set to get $500 million from settlement of mRNA lawsuit
GSK set to get $500 million from settlement of mRNA lawsuit

Time of India

time30 minutes ago

  • Time of India

GSK set to get $500 million from settlement of mRNA lawsuit

CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer and BioNTech SE in the US, which will see CureVac's former collaborator GSK receive as much as $500 million and 1% of royalties from future vaccine sales. The settlement comes as BioNTech looks to close the purchase of its former rival CureVac for about $1.25 billion. GSK will receive $370 million upfront, with another $130 million on the closing of the acquisition. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program In the wake of the race to develop Covid-19 vaccines, drugmakers launched multiple lawsuits against one another over alleged patent infringement. The litigation has spanned across Europe and the US, pitting rival vaccine manufacturers against one another in the courts. GSK worked with CureVac to develop Covid-19 vaccines but they failed, losing out to quicker, nimbler rivals. Last year, the two companies restructured their collaboration, with GSK paying CureVac up to $1.4 billion for the full rights to mRNA flu and Covid-19 vaccines it was developing with the German biotech. GSK will also receive 1% on royalties of future Pfizer-BioNTech sales of flu, Covid-19 and related combination mRNA vaccines in the US. Once BioNTech completes the purchase of CureVac, GSK will also receive 1% of royalties from future sales outside the US. Live Events While the settlement ends CureVac's litigation with Pfizer and BioNTech, it doesn't mean the same for GSK. The British drugmaker said it will continue its litigation against BioNTech and Pfizer for what it alleges is infringement of its patents.

THIS is the best time to exercise before bed to lose 6 kgs in just 30 days
THIS is the best time to exercise before bed to lose 6 kgs in just 30 days

Time of India

time30 minutes ago

  • Time of India

THIS is the best time to exercise before bed to lose 6 kgs in just 30 days

Experts agree that gentle, low-intensity activities like yoga, stretching, or a quiet walk can actually enhance sleep quality. (Image: iStock) Losing weight feels like a race against time. But what if time itself becomes the secret weapon? While most fitness advice pushes for early morning workouts, a growing wave of research suggests something rather unexpected: exercising at the right time before bed could speed up fat loss, improve metabolism, and even help in losing up to 6 kilos in a month. Sounds like a health myth? Not really. Let's break it down with facts, not fads. Morning is best for weight loss Many believe that early morning workouts, especially on an empty stomach, boost fat burn. While it's true that mornings can offer fewer distractions and steadier hormone levels, night workouts are not the enemy. In fact, studies from the University of Chicago and the Journal of Clinical Endocrinology have shown that evening exercise can increase resting metabolic rate, especially when done 90 minutes before sleep. 7:00 PM to 8:30 PM is the golden window This timeframe is when the body's core temperature is at its peak, helping muscles to perform better. A 45-minute strength training or HIIT session during this slot has shown increased calorie burn even post-workout, thanks to a phenomenon called EPOC (Excess Post-exercise Oxygen Consumption). Not just fat loss, better sleep, balanced hunger hormones, and reduced stress levels are added bonuses when evening workouts are done consistently. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Baron: Unsold Sofas May Be at Bargain Prices (Prices May Surprise You) Sofas | Search Ads Search Now Undo Exercising before bed ruins sleep This used to be a solid belief. But a review published in Sports Medicine in 2019 examined over 20 studies and found no significant negative impact on sleep when workouts were completed at least one hour before bedtime. In fact, for some, moderate evening workouts helped in reducing anxiety, leading to deeper sleep, which directly supports fat loss, especially around the belly. So, the idea that night workouts harm sleep is largely outdated, unless it's an intense session done too close to bedtime (like past 10 PM). What kind of workouts work best at night? To encourage fat loss while supporting quality sleep, the focus should be on moderate to high-intensity workouts with a calming cooldown: HIIT (20–30 mins): Short bursts of energy keep the metabolism high for hours. Strength training (30–40 mins): Builds muscle and burns calories long after the workout ends. Yoga or stretching post-workout: Helps the body wind down and prepares it for rest. Tip: Avoid excessive caffeine or pre-workout stimulants. A light protein smoothie or banana 30 minutes before exercising can boost energy without affecting sleep. Can 6 kilos really melt away in 30 days? Yes, but only when paired with clean eating, hydration, and consistent sleep. A workout alone, no matter how well-timed, won't create magic. But combined with a calorie deficit of 500-800 per day, an evening workout routine can accelerate fat loss significantly. On average, this can translate to 1.5-2 kilos per week, especially in individuals with higher starting body weight or previously sedentary lifestyles. Get the latest lifestyle updates on Times of India, along with Raksha Bandhan wishes , messages and quotes !

GSK set to get $500 million from settlement of mRNA lawsuit
GSK set to get $500 million from settlement of mRNA lawsuit

Economic Times

time30 minutes ago

  • Economic Times

GSK set to get $500 million from settlement of mRNA lawsuit

Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer and BioNTech SE in the US, which will see CureVac's former collaborator GSK receive as much as $500 million and 1% of royalties from future vaccine settlement comes as BioNTech looks to close the purchase of its former rival CureVac for about $1.25 billion. GSK will receive $370 million upfront, with another $130 million on the closing of the the wake of the race to develop Covid-19 vaccines, drugmakers launched multiple lawsuits against one another over alleged patent infringement. The litigation has spanned across Europe and the US, pitting rival vaccine manufacturers against one another in the worked with CureVac to develop Covid-19 vaccines but they failed, losing out to quicker, nimbler rivals. Last year, the two companies restructured their collaboration, with GSK paying CureVac up to $1.4 billion for the full rights to mRNA flu and Covid-19 vaccines it was developing with the German will also receive 1% on royalties of future Pfizer-BioNTech sales of flu, Covid-19 and related combination mRNA vaccines in the US. Once BioNTech completes the purchase of CureVac, GSK will also receive 1% of royalties from future sales outside the the settlement ends CureVac's litigation with Pfizer and BioNTech, it doesn't mean the same for GSK. The British drugmaker said it will continue its litigation against BioNTech and Pfizer for what it alleges is infringement of its patents.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store